Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
Athina Angelopoulou, Nikolaos Alexandris, Evangelia Konstantinou, Konstantinos Mesiakaris, Charilaos Zanidis, Konstantinos Farsalinos, Konstantinos Poulas
Topics & Concepts
ImiquimodImmunologyTLR7Innate immune systemToll-like receptorTumor necrosis factor alphaImmune systemAcquired immune systemAgonistImmunityBiologyMedicineReceptorInternal medicineCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchImmune Response and Inflammation